Clinical Trial: Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930885) titled 'Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease' on April 09.

Brief Summary: The EPOCA study (Evaluation of a POlypill and Colchicine for risk reduction in patients with established Atherosclerotic cardiovascular disease) will be a randomized, superiority, parallel, 2x2 factorial, multicenter clinical trial which will include at least 7713 and up to a maximum of 10797 participants with established atherosclerotic cardiovascular disease.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Atherothrombotic Diseases Atherosclerotic Cardiov...